Non-Small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer, which develops in the lungs and can cause symptoms like persistent cough, chest pain, and difficulty breathing.
WSD0922-FU for Advanced Non-Small Cell Lung Cancer
We are studying a new treatment for patients with advanced NSCLC who have a specific mutation and did not respond to prior therapy. The goal is to see if this treatment can help shrink tumors and improve survival.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you 18 years old or older?
- Do you have a confirmed diagnosis of non-small cell lung cancer (NSCLC)?
- Are you currently using effective birth control methods?
- Are you taking no more than 2 mg of dexamethasone daily?
- Have you had no more than 2 prior treatments for advanced NSCLC?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
WSD0922-FU
6-((3,3-Difluoro-1-Methylpiperidin-4-Yl)Oxy)-N-(3-Ethynyl-2-Fluorophenyl)-7-Methoxyquinazolin-4-Amine-Fumarate
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Centre Hospitalier Intercommunal Toulon / La Seine-Sur-Mer
Service d'oncologie pneumologie
Besançon, France
Centre Francois Baclesse
Pneumologie
Caen, France
Centre Hospitalier Universitaire De Bordeaux
Services des Maladies respiratoires
Canéjan, France
Sponsor: Wayshine Biopharm Inc.
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.